KG-1 Cells

KG-1 is a human acute myelogenous leukemia (AML) cell line derived from the bone marrow of an adult patient with erythroleukemia. This cell line is a valuable model for studying hematopoietic differentiation and leukemia, particularly due to its unique characteristics, including the expression of several hematopoietic markers. KG-1 cells are classified as immature myeloid cells that resemble early progenitor cells, which makes them a useful tool for investigating the early stages of myeloid lineage commitment and the molecular mechanisms driving leukemogenesis. KG-1 cells exhibit a high degree of plasticity, which allows them to differentiate into various hematopoietic lineages under the right experimental conditions. This characteristic is particularly important for research in understanding the regulation of hematopoiesis and the development of therapeutic strategies aimed at targeting leukemic stem cells. Additionally, KG-1 cells are known to express markers such as CD34, HLA-DR, and CD13, which are critical in both normal and malignant hematopoiesis, making them an excellent model for flow cytometry and other immunophenotyping studies. KG-1 has also been employed in drug discovery and toxicity testing, where its responsiveness to differentiation agents and chemotherapeutic drugs can be evaluated. As with all in vitro models, it is important to recognize that KG-1 cells are for research use only and not suitable for therapeutic or in vivo applications. Leukemia cell lines, Bone marrow, Acute myelogenous leukemia, Growth Conditions: Suspension, Biosafety level: BSL 1